Vol. 6 No. 2 (2009)

Articles

• Breakthrough in Diabetes Therapy … Just Around the Corner?

  William A. Rudert, Massimo Trucco

  • pdf

• The Role of the CXCL10/CXCR3 System in Type 1 Diabetes

  Akira Shimada , Yoichi Oikawa , Yoshifumi Yamada, Yoshiaki Okubo, Shosaku Narumi

  • pdf

• Histopathology of Type 1 Diabetes: Old Paradigms and New Insights

  Ken T. Coppieters, Matthias G. von Herrath

  • pdf

• Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations

  Jenny M. Phillips, Nicole M. Parish, Tim Raine, Chris Bland, Yvonne Sawyer, Hugo De La Peña, Anne Cooke

  • pdf

• Allelic Variation of Ets1 Does Not Contribute to NK and NKT Cell Deficiencies in Type 1 Diabetes Susceptible NOD Mice

  Margaret A. Jordan , Julie M. Fletcher, Alan G. Baxter, Lynn D. Poulton

  • pdf

• Comparison of Fasting Glucose with Post-Load Glucose Values and Glycated Hemoglobin for Prediction of Type 2 Diabetes: The Isfahan Diabetes Prevention Study

  Mohsen Janghorbani, Masoud Amini

  • pdf

• Prevalence of Diabetic Retinopathy and Cataract in Adult Patients With Type 1 And Type 2 Diabetes in Russia

  Ivan Dedov, Oxana Maslova, Yurii Suntsov, Lubov Bolotskaia, Tamara Milenkaia, Lena Besmertnaia

  • pdf

• Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations

  Arie Gruzman, Gali Babai, Shlomo Sasson

  • pdf